# reload+after+2024-01-22 08:44:01.391640
address1§2500 Westchester Avenue
city§Purchase
state§NY
zip§10577
country§United States
phone§412 481 2210
website§https://www.cogrx.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex for the treatment of Alzheimer's disease. The company is also developing COG0201 SHINE, a randomized double-blind and placebo-controlled for mild-to-moderate AD and is in phase II clinical trial. Its product pipeline also includes CT2168 for Synucleinopathies; and CT2074 for dry age-related macular degeneration. The company was incorporated in 2007 and is headquartered in Purchase, New York.
fullTimeEmployees§22
companyOfficers§[{'maxAge': 1, 'name': 'Ms. Lisa  Ricciardi', 'age': 63, 'title': 'CEO, President & Director', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 794039, 'exercisedValue': 0, 'unexercisedValue': 558405}, {'maxAge': 1, 'name': 'Dr. Anthony O. Caggiano M.D., Ph.D.', 'title': 'Chief Medical Officer and Head of R&D', 'fiscalYear': 2022, 'totalPay': 578483, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. John Brendan Doyle', 'age': 46, 'title': 'Chief Financial Officer', 'yearBorn': 1977, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Steven A. Weissman Ph.D.', 'title': 'VP & Head of CMC', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.706
currency§USD
dateShortInterest§1702598400
forwardEps§-1.36
exchange§NGM
quoteType§EQUITY
shortName§Cognition Therapeutics, Inc.
longName§Cognition Therapeutics, Inc.
firstTradeDateEpochUtc§1633699800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§a940fdf5-8e87-319f-94b8-efcb91259f97
gmtOffSetMilliseconds§-18000000
targetHighPrice§9.0
targetLowPrice§5.0
targetMeanPrice§6.25
targetMedianPrice§5.5
recommendationMean§1.5
recommendationKey§strong_buy
numberOfAnalystOpinions§4
quickRatio§4.205
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
